Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Stockchase Insights
FMC CorpFMCDON'T BUYOct 07, 2025
Stockchase InsightsUnknown
$31.38
Stock price when the opinion was issued
$11.27
As of Jun 11, 2026. Market Open.
chemicals
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentPAST TOP PICK
Premium contentPAST TOP PICK
Premium contentTOP PICK
Stockchase Research Editor: Michael O'Reilly
This global producer of agricultural herbicides and insecticides, recently reported a 49% increase in free cash flow. North American sales are up 24% over the year and management expects a 15% increase in earnings over the second half of 2024. It trades at 19x earnings, under 2x book and supports a 36% ROE. Its dividend is backed by a payout ratio under 20% of cash flow. We recommend setting a stop-loss at $52, looking to achieve $72 -- upside potential of 17%. Yield 3.7%
(Analysts’ price target is $71.94)chemicals
BUY
TOP PICK
FMC, $4B market cap, down 47% in the past year, is very cheap at 9X earnings, with a 7.2% dividend. But debt is extremely high (more than 10X recent 12-month cash flow) and earnings have stalled. 2026E EPS is expected to be less than it was seven years ago. The Q2 was decent, but free cash flow has been running negative on a 12-month basis. It did affirm guidance, but this is really a debt issue. If the global economy slows, their business is not likely to see big growth, but of course the debt will still be there. Going into year end tax selling we would sit this one out. We have no idea how Morningstar sees it tripling.
Unlock Premium - Try 5i Free